Re: FDA approves Vraylar - 97 week phase III study » Tomatheus

Posted by SLS on September 20, 2015, at 14:52:26

In reply to Re: FDA approves Vraylar - 97 week phase III study » SLS, posted by Tomatheus on September 20, 2015, at 13:51:31

> Thank you for posting this information, Scott. Judging from the press release that I posted, it seemed that the only trials that had been conducted on Vraylar were three weeks in length.
The more recent short trials were only needed as supplements to the earlier long trials in order to more precisely determine dosage recommendations. Safety and efficacy had already been demonstrated.

- Scott
Some see things as they are and ask why.
I dream of things that never were and ask why not.
- George Bernard Shaw

Thread

FDA approves Vraylar for schizophrenia, bipolar Tomatheus 9/17/15
...
Re: FDA approves Vraylar for schizophrenia, bipolar Lamdage22 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar Christ_empowered 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Lamdage22 Tomatheus 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Christ_empowered Tomatheus 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Tomatheus herpills 9/19/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Christ_empowered herpills 9/19/15
Re: FDA approves Vraylar for schizophrenia, bipolar Lamdage22 9/20/15
FDA approves Vraylar - 97 week phase III study SLS 9/20/15
Re: FDA approves Vraylar - 97 week phase III study » SLS Tomatheus 9/20/15
Re: FDA approves Vraylar - 97 week phase III study Lamdage22 9/20/15
Re: FDA approves Vraylar for schizophrenia, bipolar Lamdage22 9/20/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Lamdage22 Tomatheus 9/20/15
Re: FDA approves Vraylar - 97 week phase III study » Tomatheus SLS 9/20/15
Re: FDA approves Vraylar - 97 week phase III study Lamdage22 9/21/15

Post a new follow-up

Notify the administrators

Start a new thread

poster:SLS thread:1082598
URL: http://www.dr-bob.org/babble/20150901/msgs/1082743.html